United Therapeutics Corporation (FRA:UTH)

United Therapeutics Revenue

United Therapeutics had revenue of $799.50M USD in the quarter ending September 30, 2025, with 6.76% growth. This brings the company's revenue in the last twelve months to $3.13B, up 13.50% year-over-year. In the year 2024, United Therapeutics had annual revenue of $2.88B with 23.63% growth.

• Revenue (ttm): $3.13B
• Revenue Growth: +13.50%
• P/S Ratio: 6.77
• Revenue / Employee: $2.40M
• Employees: 1,305
• Market Cap: 18.05B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.88B	549.90M	23.63%
Dec 31, 2023	2.33B	391.20M	20.20%
Dec 31, 2022	1.94B	250.80M	14.88%
Dec 31, 2021	1.69B	202.20M	13.63%
Dec 31, 2020	1.48B	34.50M	2.38%
Dec 31, 2019	1.45B	-179.00M	-11.00%
Dec 31, 2018	1.63B	-97.50M	-5.65%
Dec 31, 2017	1.73B	126.50M	7.91%
Dec 31, 2016	1.60B	133.00M	9.07%
Dec 31, 2015	1.47B	177.30M	13.76%
Dec 31, 2014	1.29B	171.52M	15.36%
Dec 31, 2013	1.12B	200.91M	21.93%
Dec 31, 2012	916.08M	172.89M	23.26%
Dec 31, 2011	743.18M	150.28M	25.35%
Dec 31, 2010	592.90M	234.02M	65.21%
Dec 31, 2009	358.88M	77.38M	27.49%
Dec 31, 2008	281.50M	70.55M	33.45%
Dec 31, 2007	210.94M	51.31M	32.14%
Dec 31, 2006	159.63M	43.72M	37.71%
Dec 31, 2005	115.92M	-	-